ReMYND
Developing treatments for Alzheimer’s, diabetes and other diseases caused by cellular dysfunction. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$53—79m (Dealroom.co estimates Jan 2021.)
Company register number 0476.910.101
Leuven Flemish Brabant (HQ)
Authorizing premium user...